Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dapagliflozin propanediol
Drug ID BADD_D00579
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D09763
MeSH ID Not Available
PubChem ID 24906252
TTD Drug ID Not Available
NDC Product Code 54864-668; 64220-197; 54864-665; 66651-924; 71796-006; 14501-0091; 54864-666; 54864-669; 69037-0038; 54864-667; 67835-0023
UNII 887K2391VH
Synonyms Not Available
Chemical Information
Molecular Formula C24H35ClO9
CAS Registry Number 960404-48-2
SMILES CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Blood phosphorus increased13.11.01.016---
Escherichia urinary tract infection11.02.10.003; 20.08.02.009---
Dyslipidaemia14.08.04.015---
Urine output increased13.13.03.002---
Genital infection fungal11.03.05.003; 21.10.03.003---
Genitourinary tract infection11.01.14.005; 20.08.02.003; 21.10.03.005---
Penile infection11.01.19.002; 21.09.03.003--
Genital infection female11.01.10.011; 21.14.04.003---
Renal impairment20.01.03.010---
Genital infection male11.01.19.006; 21.09.03.006---
Vulvovaginal mycotic infection11.03.05.004; 21.14.02.004---
Balanoposthitis infective11.01.19.007; 21.09.03.007---
Bacterial vulvovaginitis11.02.01.052; 21.14.02.013---
The 2th Page    First    Pre   2    Total 2 Pages